Encompass Health (EHC) Downgraded by Zacks Investment Research to Sell
According to Zacks, “Encompass Health Corporation provides inpatient rehabilitation hospitals and home-based care services. It offers facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. Encompass Health Corporation, formerly known as HealthSouth Corporation, is headquartered in Birmingham, Alabama. “
Separately, Jefferies Financial Group started coverage on Encompass Health in a research report on Thursday, December 20th. They set a buy rating on the stock. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and nine have issued a buy rating to the company’s stock. The company has a consensus rating of Buy and a consensus price target of $75.56.
Encompass Health (AMEX:EHC) last issued its quarterly earnings data on Thursday, February 7th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.79 by $0.01. The firm had revenue of $1.10 billion for the quarter, compared to the consensus estimate of $1.09 billion. The company’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.70 EPS.
The business also recently announced a quarterly dividend, which was paid on Monday, April 15th. Shareholders of record on Monday, April 1st were issued a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of ∞. The ex-dividend date was Friday, March 29th.
In related news, Director Leo I. Higdon, Jr. bought 1,000 shares of the business’s stock in a transaction on Thursday, March 7th. The shares were purchased at an average cost of $58.84 per share, with a total value of $58,840.00. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 1.60% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. lifted its holdings in Encompass Health by 2.2% during the 3rd quarter. Vanguard Group Inc. now owns 9,285,576 shares of the company’s stock worth $723,811,000 after buying an additional 200,890 shares during the period. Morgan Stanley lifted its holdings in Encompass Health by 25.8% during the 3rd quarter. Morgan Stanley now owns 638,008 shares of the company’s stock worth $49,731,000 after buying an additional 130,728 shares during the period. Rehmann Capital Advisory Group lifted its holdings in Encompass Health by 8,546.8% during the 3rd quarter. Rehmann Capital Advisory Group now owns 193,082 shares of the company’s stock worth $2,477,000 after buying an additional 190,849 shares during the period. Nordea Investment Management AB lifted its holdings in Encompass Health by 13.6% during the 3rd quarter. Nordea Investment Management AB now owns 57,325 shares of the company’s stock worth $4,468,000 after buying an additional 6,856 shares during the period. Finally, TIAA CREF Investment Management LLC lifted its holdings in Encompass Health by 5.0% during the 3rd quarter. TIAA CREF Investment Management LLC now owns 1,362,083 shares of the company’s stock worth $106,174,000 after buying an additional 64,497 shares during the period. 93.18% of the stock is currently owned by hedge funds and other institutional investors.
About Encompass Health
Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.
Further Reading: Intrinsic Value and Stock Selection
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.